Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 931-937

John Wiley & Sons Inc

Access to resources Recommend Favorite

Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double‐blind placebo‐controlled trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 754-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

A double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea

By Eccles Ronald   Holbrook Amanda   Jawad Martez  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2689-2699

Informa Healthcare

Access to resources Recommend Favorite

A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1

By Emberlin J. C.   Lewis R. A.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2423-2431

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

By Cooper Cyrus   Reginster Jean-Yves   Chapurlat Roland   Christiansen Claus   Genant Harry   Bellamy Nicholas   Bensen William   Navarro Federico   Badurski Janusz   Nasonov Evgeny   Chevalier Xavier   Sambrook Philip N.  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 231-239

Informa Healthcare

Access to resources Recommend Favorite